Vimarsana
Biggest News Aggregation in the World

Multi Centre News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multi Centre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multi Centre Today - Breaking & Trending Today

BBCNEWS Victoria Derbyshire January 17, 2018 - Vimarsana News

BBCNEWS Victoria Derbyshire January 17, 2018

Working hours doesnt mean we are more productive, especially when it negatively impacts our health and our ability to do ourjob. Well hearfrom Companies Pioneering new approaches to improve peoples Work Life Balance. Hello. Welcome to the programme, were live until 11 00am this morning. Clearly this morning we want to know about your Work Life Balance. Do you, have you, worked crazy hours and done something about that . Is it worth it . If you are a boss, how do you work with your staff . Have you been able to come up with a solution. Use the hashtag victorialive, send me an email victoria bbc...

Foundation Laid For Can Youth Livelihood School At Hazadisa Village In Nagaland - Vimarsana News

Foundation Laid For Can Youth Livelihood School At Hazadisa Village In Nagaland

DIMAPUR — To create a conducive environment for the women and youth in Dhansiripar to pursue self-development, Can Youth Livelihood School for Rural Women and

Development is not only about road construction: Hekani - Vimarsana News

Development is not only about road construction: Hekani

Advisor for Department of Industries & Commerce, Hekani Jakhalu while noting on the importance of road construction needed for connectivity mentioned that people’s concept of development of a society should not only be confined to it alone.

Ground-breaking results in Phase 2 scleroderma study by Certa Therapeutics demonstrates improvement in more than 60% of patients - Vimarsana News

Ground-breaking results in Phase 2 scleroderma study by Certa Therapeutics demonstrates improvement in more than 60% of patients

Data from Certa Therapeutics' Phase 2 clinical trial with development candidate FT011 demonstrates clinically meaningful improvements for more than 60 percent of patients with scleroderma after 12 weeks of treatment; Clinically meaningful improvements were reported in CRISS (the key composite endpoint for systemic sclerosis) lung function, SHAQ-DI and Physician Global Assessment; The trial results also showed FT011 to be safe and well tolerated in this patient population; FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs; Certa's nov...

TRANSFORM 1 enrollment completed: A crucial RCT ready to redefine the DCB Angioplasty Mechanism - Vimarsana News

TRANSFORM 1 enrollment completed: A crucial RCT ready to redefine the DCB Angioplasty Mechanism

Birmingham [England], September 14 (ANI/PRNewswire): Concept Medical announces the successful completion of the TRANSFORM 1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch Sirolimus Coated Balloon). The Randomized Controlled Trial (RCT) was conceptualized with the aim of understanding how the treatment indications and applications of Drug-Coated Balloon (DCB) in coronary artery disease (CAD) can be broadened. This prospective, randomized, multi-centre, RCT focusing on small vessels, de-novo coronary lesion treatment enrolled the culminating 114th patient on...